Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315]
aState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, China
bJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
cState Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
dDepartment of Oncology, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
* Corresponding authors.
收起